User menu

A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells.

Bibliographic reference Jacquy, C ; Sorée, A ; Lambert, F. ; Bosly, André ; Ferrant, Augustin ; et. al. A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells.. In: British journal of haematology, Vol. 110, no. 3, p. 631-637 (2000)
Permanent URL http://hdl.handle.net/2078.1/23240
  1. Philip T., New England Journal of Medicine, 316, 1493 (1987)
  2. Takvorian T., New England Journal of Medicine, 316, 1499 (1987)
  3. Bosly A., Nouvelle Revue Francaise d'Hematologie, 35, 21 (1993)
  4. Gianni Alessandro M., Bregni Marco, Siena Salvatore, Brambilla Cristina, Di Nicola Massimo, Lombardi Fabrizio, Gandola Lorenza, Tarella Corrado, Pileri Alessandro, Ravagnani Fernando, Valagussa Pinuccia, Bonadonna Gianni, High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma, 10.1056/nejm199705013361804
  5. Haioun C., Journal of Clinical Oncology, 15, 1131 (1997)
  6. Haioun C., Lepage E., Gisselbrecht C., Coiffier B., Doyen Ch., Morel P., Attal M., Tilly H., Deconinck E., Gaulard Ph., Reyes F., 10.1023/a:1008291723029
  7. Hardingham J.E., Bone Marrow Transplantation, 1, 15 (1993)
  8. McCann J.C., Biology of Blood and Marrow Transplantation, 2, 37 (1996)
  9. Wu G. Q., Sharp J. G., Wu G., Vose J., Greiner T. C., Chan W. C., The detection of minimal lymphoma by molecular and combined culture-molecular methods, 10.1046/j.1365-2141.1997.4903295.x
  10. Johnson P.W.M., Journal of Clinical Oncology, 12, 798 (1994)
  11. Andersen N.S., Blood, 90, 4212 (1997)
  12. Corradini P., Blood, 89, 724 (1997)
  13. Jacquy C, Lambert F, Soree A, Van Daele S, Heusterspreute M, Bosly A, Ferrant A, Parma J, Bron D, Martiat P, Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?, 10.1038/sj.bmt.1701637
  14. Lombardo James F, Hwang Tae Sook, Maiese Russell L, Millson Alison, Segal Glenn H, Optimal primer selection for clonality assessment by polymerase chain reaction analysis III. Intermediate and high-grade B-cell neoplasms, 10.1016/s0046-8177(96)90111-2
  15. Schmitz N, Dreger P, Linch D.C, Goldstone A.H, Boogaerts M.A, Demuynck H.M.S, Ferrant A, Zander A, Link H, Barge A, Borkett K, Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients, 10.1016/s0140-6736(96)90536-x
  16. Majolino I., Journal of Clinical Oncology, 15, 509 (1997)
  17. Sharp J.G., Journal of Clinical Oncology, 14, 214 (1996)
  18. Zwicky C.S., Blood, 88, 3314 (1996)
  19. Williams C.D., Journal of Clinical Oncology, 14, 2454 (1996)
  20. Harris N.L., Blood, 84, 1361 (1994)
  21. Aubin J., Leukemia, 9, 470 (1995)
  22. Nizet Y., Blood, 82, 1618 (1993)
  23. Jacquy C., Delepaut B., Van Daele S., Vaerman J. L., Zenebergh A., Brichard B., Vermylen C., Cornu G., Martiat P., A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse, 10.1046/j.1365-2141.1997.1792996.x
  24. Landman-Parker J., Aubin J., Delabesse E., Tabone M-D., Adam M., Millien C., Leboeuf D., Buzyn-Veil A., Dollfus C., Leverger G., Macintyre E. A., Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia, 10.1046/j.1365-2141.1996.d01-1917.x
  25. Sykes P.J., Biotechniques, 13, 444 (1992)
  26. Ouspenskaia M.V., Leukemia, 9, 321 (1995)